Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Ismael Luis Calandri, Jeffrey S Phillips, Pontus Tideman, et al.
JAMA
|
July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
Molecular Neurodegeneration
|
February 16, 2024
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
Juan Lantero-Rodriguez, Gemma Salvadó, Anniina Snellman, et al.
JAMA Neurology
|
February 6, 2023
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
Niklas Mattsson-Carlgren, Gemma Salvadó, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 18, 2026
Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts
Alexandra König, Johannes Tröger, Elisa Mallick, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Sebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
The Lancet. Neurology
|
March 21, 2026
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study
Niklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 27, 2026
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
Ayesha Fawad, Sophie M van der Landen, Pontus Tideman, et al.
Nature Medicine
|
November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Nature Medicine
|
April 9, 2025
Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform
Sebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Ismael Luis Calandri, Jeffrey S Phillips, Pontus Tideman, et al.
JAMA
|
July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
Molecular Neurodegeneration
|
February 16, 2024
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
Juan Lantero-Rodriguez, Gemma Salvadó, Anniina Snellman, et al.
JAMA Neurology
|
February 6, 2023
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
Niklas Mattsson-Carlgren, Gemma Salvadó, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 18, 2026
Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts
Alexandra König, Johannes Tröger, Elisa Mallick, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Sebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
The Lancet. Neurology
|
March 21, 2026
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study
Niklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 27, 2026
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
Ayesha Fawad, Sophie M van der Landen, Pontus Tideman, et al.
Nature Medicine
|
November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Nature Medicine
|
April 9, 2025
Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform
Sebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
Page
of 4